Opening book details…
About this Medicine article
A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial by Saridaki, Z; Androulakis, N; Vardakis, N; Vamvakas, L; Kabouraki, E; Kalbakis, K; Hatzidaki, D; Voutsina, A; Mavroudis, D; Georgoulias, V; Souglakos, J is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Saridaki, Z; Androulakis, N; Vardakis, N; Vamvakas, L; Kabouraki, E; Kalbakis, K; Hatzidaki, D; Voutsina, A; Mavroudis, D; Georgoulias, V; Souglakos, J
- Publisher
- Nature Publishing Group; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0007-0920)
- Published
- 2012
- Field
- Medicine (Health Sciences)